The FDA has approved EMSAM (selegiline), a transdermal patch, for the treatment of major depression. Selegeline is a MAOI originally used to treat Parkinsons. MAOIs belong to an old class of antidepressants, typically used as a last resort. When taken orally, side effects with these meds tend to be onerous, including risk of tyramine reaction and resulting hypertensive crisis, which necessitates severely restricting ones diet.
The patch was developed by Somerset Pharmaceuticals,...
Read moreThanks to the FDA, I now have a clutter-free, neatly organized medicine cabinet for the first time since stockpiling it for the arrival of... Read more »
When I first read the headline that the FDA had approved the first anti-psychotic for use in children, I was, shall we say, apprehensive.... Read more »
Since 2007, the FDA has been discussing and debating the development of Risk Evaluation and Mitigation Strategies (REMS) for opioid... Read more »
Yesterday, the FDA approved the Medtronic Reclaim Deep Brain Stimulator device for the treatment of obsessive-compulsive disorder (OCD).... Read more »
The U.S. Food and Drug Administration has approved Abilify as an add-on treatment for people who suffer from major depressive disorder (MDD).... Read more »
In a recent study, an experimental obesity medication called Contrave was found to both lessen symptoms of depression and improve eating control in... Read more »
LOS ANGELES (Ivanhoe Broadcast News) -- About 17 million Americans suffer depression, which is the fourth-leading cause of disability in this... Read more »
New research suggests that some teens are smoking marijuana not just for recreation but to self-medicate emotional problems, sleep difficulties,... Read more »
You can wear a patch to quit smoking, a patch to fend of pregnancy, and pretty soon, youll be able to wear a patch to treat depression. Emsam, an... Read more »